Robert Lorne Hopfner, Director at Vaxcyte, Inc. (PCVX), sold 60,958 shares at $25.35 ($1.5M) on 2021-01-20, disclosed to the SEC on 2021-01-22.
Open-market sale of $1.5M PCVX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.35 | 19,046 | $483K | 31.3% |
| 2 | $25.35 | 19,046 | $483K | 31.3% |
| 3 | $25.11 | 100 | $3K | 0.2% |
| 4 | $25.16 | 11,383 | $286K | 18.6% |
| 5 | $25.16 | 11,383 | $286K | 18.6% |
| Total | $25.28 avg | 60,958 |
| $1.5M |
| 100% |
| Filing → |
| INZY | BUY | 2023-05-15 | $5.7M | — | Filing → |
| INZY | BUY | 2023-03-30 | $3.1M | — | Filing → |
| INZY | BUY | 2023-03-29 | $1.7M | — | Filing → |